Mildin (Loratadine)

Loratadine works by selectively binding to peripheral H1‑histamine receptors, preventing histamine from activating these receptors. This inhibition stops the cascade that leads to vasodilation, increased vascular permeability, and nerve stimulation, thereby reducing the classic signs of an allergic response such as itching, swelling, and redness.

The appropriate dose of Mildin is determined by a qualified prescriber based on the patient’s age, weight, medical history, and the specific condition being treated. Healthcare professionals follow local prescribing guidelines and adjust the regimen as needed for optimal safety and effectiveness.

Safety data for loratadine during pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before starting Mildin. The prescriber will weigh the therapeutic need against any possible fetal or infant exposure.

To request Mildin, visit the product page on gnhindia.com and submit an enquiry with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifying trade or institutional credentials before providing a quotation, availability details, shipping options, and any necessary import documentation.

Mildin (loratadine) is a second‑generation antihistamine, which generally causes less sedation than first‑generation agents such as diphenhydramine. It offers once‑daily dosing, a favorable safety profile, and effective symptom control for allergic rhinitis, conjunctivitis, and urticaria, making it a preferred option for patients who need minimal drowsiness.

Mildin should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in their original container, protect them from moisture, excessive heat, and direct sunlight. Do not store in the bathroom or near a kitchen sink where humidity is high.

Mildin is taken orally, usually with or without food, as directed by a healthcare professional. The tablet should be swallowed whole with a glass of water and not chewed or crushed, unless the prescriber provides specific instructions for a particular patient.

Serious but rare risks include hypersensitivity reactions such as rash, hives, facial swelling, or angio‑edema, and in very uncommon cases, anaphylaxis. If any signs of a severe allergic reaction appear, seek immediate medical attention. Patients should also be aware of rare cardiac effects like palpitations.

Individuals with a known hypersensitivity to loratadine or any component of the tablet should not use Mildin. Caution is advised for patients with severe liver disease, pregnant or nursing women without medical guidance, and those taking medications that strongly inhibit CYP3A4 or CYP2D6, unless a prescriber determines it is safe.